Glaukos Corporation (GKOS) vs Smith & Nephew SNATS, Inc. (SNN)
Glaukos Corporation and Smith & Nephew SNATS, Inc. are both Medical Devices companies. Smith & Nephew SNATS, Inc. is the larger, with a market value of $11.2B against $9.1B — 1.2× the size. Glaukos Corporation has negative trailing earnings, so its P/E is not meaningful; Smith & Nephew SNATS, Inc. trades at 32.8×. Glaukos Corporation grew revenue faster over the last twelve months: 41.6% against 4.81%. Smith & Nephew SNATS, Inc. has the higher net margin (6.71% vs −30.7%) and the higher return on invested capital (0.00% vs −26.1%). Across the 19 metrics below, Smith & Nephew SNATS, Inc. leads on 13 and Glaukos Corporation on 6.
Valuation
Profitability
| Metric | GKOS | SNN | Medical Devices median |
|---|---|---|---|
| Gross margin | 79.12% | 70.52% | 56.01% |
| Operating margin | (31.55%) | 0.00% | (15.03%) |
| Net margin | (30.68%) | 6.71% | (20.40%) |
| Free cash flow margin | (1.99%) | 0.00% | (7.24%) |
| Return on equity | (25.98%) | 0.00% | (15.32%) |
| Return on assets | (19.72%) | 0.00% | (19.72%) |
| Return on invested capital | (26.07%) | 0.00% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack